The EMA said people who had previously sustained capillary leak syndrome should not receive AstraZeneca’s Covid-19 vaccine. Photo: AFP
Coronavirus: EU flags another rare blood condition as side effect of AstraZeneca vaccine
- The European Medicines Agency’s safety committee said that capillary leak syndrome must be added as a new side effect to labelling on the shot
- It said people who had previously sustained the condition should not receive the vaccine
The EMA said people who had previously sustained capillary leak syndrome should not receive AstraZeneca’s Covid-19 vaccine. Photo: AFP
